Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Hematologic changes following burns.
Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.
Primum non nocere: antithombotics after intracerebral hemorrhage?
Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. Leuk Lymphoma. 2001 Jul; 42(3):417-27.
View in:
PubMed
subject areas
Antibiotics, Antineoplastic
Biological Transport
Cell Division
Cell Survival
DNA Primers
Drug Synergism
Gene Expression Regulation, Neoplastic
Genes, p53
Hematopoietic Stem Cells
Humans
Idarubicin
Kinetics
Lymphoma
Oligodeoxyribonucleotides
Polymerase Chain Reaction
Time Factors
Tumor Cells, Cultured
Tumor Suppressor Protein p53
authors with profiles
Michael R. Bishop